EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Voriconazole-induced liver injury: incidence patterns and risk factors in a retrospective cohort

Yan Lou iD, Yu Wang iD, Jing Liu, Yu-Jing Wang, Jiaqi Wang, Shuang Ma, Zong-Ming Yang, Jing-Song Li iD, Yun-Qing Qiu iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00487-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Yan Lou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation, The First Affiliated Hospital, College…. Hauptthemen laut MEDLINE: Voriconazole, Antifungal Agents, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project of the Zhejiang Medical Association, Major Project under the Basic Public Welfare Research Program of Zhejiang Province, Major Program of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Voriconazole, a first-line therapy for invasive aspergillosis, carries hepatotoxicity risks lacking comprehensive epidemiological characterization. Current evidence is limited by heterogeneity in diagnostic criteria (e.g., varying thresholds for liver function abnormalities across studies), insufficient sample sizes, and inadequate adjustment for comorbidities, which compromises risk assessment accuracy. This study aims to systematically characterize the epidemiological profile of voriconazole-induced liver injury and identify modifiable independent risk factors. We analyzed 7,659 voriconazole-treated adults (2007–2020) from the First Affiliated Hospital of Zhejiang University to determine incidence and injury subtypes. Univariable and multivariable logistic regression identified risk factors, with model performance evaluated by ROC (receiver-operating characteristic) analysis; sensitivity analyses addressed potential confounders. In our results, voriconazole-induced liver injury occurred in 11.32% of patients, predominantly manifesting as hepatocellular (5.01%, 279/630), cholestatic (5.19%, 289/630), and mixed-pattern injuries (1.11%, 62/630). Key modifiable risk factors included intravenous administration (odds ratio [OR] = 1.88, 95% confidence interval [CI]: 1.43–2.46). Non-modifiable predictors comprised baseline elevated urea (OR = 1.47, 95% CI: 1.08–2.02), elevated triglycerides (TG) (cholestatic injury: OR = 1.47, 95% CI: 1.08–2.02), elevated C-reactive protein (CRP) (cholestatic injury: OR = 1.47, 95% CI: 1.08–2.02), pre-existing liver disease (liver cirrhosis, OR = 2.16, 95% CI: 1.58–2.96), diabetes (OR = 2.19, 95% CI: 1.70–2.80), and transplant status (hematopoietic stem cell transplantation, OR = 2.93, 95% CI: 1.85–4.65). Using this clinically substantial cohort ( n =7,659), we proposed a risk-stratification framework incorporating administration route optimization and comorbidity-specific monitoring, supporting personalized risk-benefit analysis in antifungal therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VoriconazoleAntifungal AgentsChemical and Drug Induced Liver InjuryHumansMaleFemaleMiddle AgedRisk FactorsRetrospective StudiesIncidenceAgedAdult

Stichwörter der Autor:innen

drug-induced liver injuryincidence patternsrisk factorsvoriconazole

Substanzen

VoriconazoleAntifungal Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republ…
  • Research Center for Healthcare Data Science, Zhejiang Lab, Hangzhou, Zhejiang, People's Republic of China.
  • Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Engineering Research Center of EMR and Intelligent Expert Systems, Ministry of Education, Key Laboratory for Biomedical Engineering of Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhe…

ORCID-Profile: Yan Lou, Yu Wang, Jing-Song Li, Yun-Qing Qiu

Förderung

  • Key Project of the Zhejiang Medical Association
  • Major Project under the Basic Public Welfare Research Program of Zhejiang Province
  • Major Program of National Natural Science Foundation of China
  • International Cooperation and Exchange Programs of the National Natural Science Foundation of China
  • Key Project under the Zhejiang Province and Ministry Co-construction Plan

Zitieren

APA

Lou, Y., Wang, Y., Liu, J., Wang, Y. J., Wang, J., Ma, S., Yang, Z. M., Li, J. S., & Qiu, Y. Q. (2025). Voriconazole-induced liver injury: incidence patterns and risk factors in a retrospective cohort. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00487-25

Vancouver

Lou Y, Wang Y, Liu J, Wang YJ, Wang J, Ma S, et al. Voriconazole-induced liver injury: incidence patterns and risk factors in a retrospective cohort. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00487-25

BibTeX
@article{Lou2025,
  author = {Lou, Yan and Wang, Yu and Liu, Jing and Wang, Yu-Jing and Wang, Jiaqi and Ma, Shuang and Yang, Zong-Ming and Li, Jing-Song and Qiu, Yun-Qing},
  title = {Voriconazole-induced liver injury: incidence patterns and risk factors in a retrospective cohort},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00487-25}
}
Kostenlos starten →